pie de potro

Coltsfoot (Tussilago farfara L.): A Comprehensive Reference

1. Identity, Taxonomy, and Botanical Description

Scientific Classification and Nomenclature

Tussilago farfara, commonly known as coltsfoot, is a plant in the tribe Senecioneae in the family Asteraceae, native to Europe and parts of western and central Asia. It is the only accepted species in the genus Tussilago, although more than two dozen other species have at one time or another been considered part of this group. Most of these are now regarded as members of other genera (Chaptalia, Chevreulia, Farfugium, Homogyne, Leibnitzia, Petasites, Senecio).

According to the Plants of the World Online database, Tussilago farfara L. is the only accepted name for the plant, with ten synonyms; those with the highest confidence levels include Cineraria farfara (L.) Bernh., Tussilago alpestris Hegetschw., Tussilago radiata Gilib., and Tussilago umbertina Borbás.

Etymology and Common Names

The name tussilago is derived from the Latin tussis, meaning cough, and ago, meaning to cast or to act on. The term farfara is believed to be derived from farfer, meaning "mealy," referring to the white tomentum on young leaves. The English common name "coltsfoot" is a 16th-century translation of the medieval Latin name pes pulli, meaning "foal's foot." Additional common names include coughwort, horsehoof, Son-before-the-father, and British tobacco. In the Chinese Pharmacopoeia (2015), the species has been registered as Kuan-Dong-Hua; it is known as podbel (meaning "bottom is white") in Bulgaria, and as Kantoka in Japan.

Morphology and Distribution

Coltsfoot is a perennial herbaceous plant that spreads by seeds and rhizomes. The plant has two types of leaves: flowering stem leaves (linear and small, arranged at intervals, with sparse long hairs and purple-tipped glands) and basal leaves (developed after the flowering stems, heart-shaped, around 13.8 inches tall, irregularly arranged, and with slightly toothed margins). The coltsfoot flowers are yellow, similar to dandelions, but bear disc florets and numerous ray florets borne on scaly stems.

This plant is unusual in that the flowers bloom and die before the appearance of any leaves, which earned it the name "son before the father" in earlier times. The plant is native to Europe and parts of Western and Central Asia. It now also grows throughout damp areas of North America, where it was introduced from Europe, probably by early settlers who cultivated it for its medicinal properties, and it now invades moist, open or partly shaded disturbed areas throughout the northeastern United States.

Plant Parts Used

The flowers, leaves, and roots of coltsfoot have all been used as herbal medicines, although the roots are generally avoided now due to their higher pyrrolizidine alkaloid content. In Europe, the leaves have been used principally, whereas in other countries the whole plant is used. Traditional Chinese Medicine preferentially uses the flower buds (Kuan Dong Hua), which typically contain lower levels of pyrrolizidine alkaloids compared to the leaves.

2. Traditional and Historical Use

Ancient and Classical European Use

Dioscorides, a 1st-century Greek physician, recommended coltsfoot for dry coughs. During the following centuries, the plant was commonly smoked to promote easier breathing and lessen the symptoms of lung ailments. Culpeper's Complete Herbal states that the fresh leaves or juice are cooling and drying, and were to be used for a hot, dry cough, wheezing, and shortness of breath.

Coltsfoot was so famous for dispelling persistent coughs that old French herbalist shop signs often displayed a coltsfoot flower painted on their facade. Coltsfoot appears in the first edition of De historia stirpium commentarii insignes, a celebrated herbal produced by Leonhart Fuchs in 1542, featuring over 500 hand-colored woodcut illustrations.

European Traditional Medicine

In traditional Austrian medicine, Tussilago farfara leaves were used internally (as tea or syrup) or externally (directly applied) for treatment of disorders of the respiratory tract, skin, locomotor system, viral infections, flu, colds, fever, rheumatism, and gout. One of the first herbs described in the literature of traditional medicine, coltsfoot was used mainly for the treatment of asthma, bronchitis, and emphysema as a cough suppressant.

In Turkey, it was used to treat burns, and in Ukraine and Poland, to treat ulcers. In Russia and China, it was used to treat diarrhea, skin diseases, wounds, and blemishes. Topically, the fresh, bruised leaves were applied to boils, abscesses, and suppurating ulcers, while a poultice of the flowers was used to soothe and support healing of inflamed skin disorders such as eczema, ulcers, sores, varicose veins, and insect bites.

Traditional Chinese Medicine

The flower bud of T. farfara has been used for more than 2,000 years for the treatment of cough, phlegm, bronchitis, and asthmatic conditions. It has been recorded in all editions of the Chinese Pharmacopoeia and applied in many Chinese patent medicines. As recorded in "Ten Effective Remedies," honey-processed Farfarae Flos (H-FF) can enhance the moistening of the lung for arresting cough, indicating that honey processing enhances the clinical effect.

Traditional Preparation Methods

Usually coltsfoot herb (leaves or flowers, sometimes by decoction) was made into a tea. Other uses included smoking the herb and making a flower poultice to treat skin conditions. An extract of the fresh leaves was also used to make cough drops and hard candy. European folk healers developed smoking traditions with dried coltsfoot leaves centuries ago, using the herb alone or blended with mullein and other respiratory plants. Coltsfoot has also been consumed as a food product in certain confectionery products, such as Coltsfoot Rock.

3. Phytochemistry: Key Constituents and Active Compounds

Overall Chemical Complexity

Quantitative analysis using methods such as GC-MS and UHPLC-MRMHR has indicated the presence of a rich pool of more than 150 chemicals in coltsfoot leaves and buds, including sesquiterpenes, phenolic acids, flavonoids, chromones, pyrrolizidine alkaloids (PAs), and others. The major chemical classes are described in detail below.

Sesquiterpenoids

Among the better-known constituents is tussilagone, a sesquiterpenoid often discussed as a marker compound. The flower buds of coltsfoot contain tussilagone, a sesquiterpenoid that has shown a variety of pharmacological activities, including anti-inflammatory properties. Other sesquiterpenoids identified include bisabolene epoxide and farfaratin. Triterpenes such as amyrin and bauerenol and phytosterols including sitosterol, stigmasterol, and taraxasterol have also been identified.

Polyphenols: Flavonoids and Phenolic Acids

The flavonoids in coltsfoot have anti-inflammatory, antispasmodic, and antitussive actions, which help to relax the muscles in the respiratory system, soothing bronchial spasms and easing cough. Quantitative analysis of coltsfoot leaves reveals relatively high and balanced contents of flavonoids (0.7–1.3%) and polysaccharides (swelling index: 8.0–14.5); notably, flavonoids and mucilage fluctuate in only a small range (coefficient of variation 11–13%), regardless of shading and harvest time.

Caffeoylquinic acids, organic compounds abundant in coltsfoot, contribute to the antitussive, expectorant, and anti-inflammatory properties of the herb, with an additional hepatostimulant effect that may cause toxicity if consumed in large doses.

Mucilage and Polysaccharides

Mucilage, bitter glycosides, and tannins are considered the major constituents of coltsfoot. These are thought to give the herb anti-inflammatory and antitussive (cough prevention and treatment) activity. Due to its mucilage content, coltsfoot has a demulcent action which can be used to soothe irritations in the gastrointestinal tract and treat inflammatory digestive disorders, especially where there is ulceration.

Pyrrolizidine Alkaloids (PAs)

The primary PAs in coltsfoot include senkirkine, senecionine, seneciphylline, and integerrimine. PA content varies widely (0.0015% to 0.04% by weight) depending on growing conditions, harvest timing, and which plant part is used. The amount of PAs in leaves of T. farfara has been detected in a wide range from 0.06 to 1.04 μg g⁻¹ of dry matter. Coltsfoot leaves are characterized by a high variability in the content of toxic PAs, much higher than in the case of the main active compounds, especially flavonoids and mucilage.

Other Constituents

Additional constituents include choline, volatile oil, zinc, magnesium, potassium, calcium, and vitamins A, B6, B12, and C. The flower bud (Farfarae Flos) specifically contains volatile oils, phenolic acids, flavonoids, polysaccharides, sterols, alkaloids, and terpenes.

4. Mechanisms of Action

Anti-inflammatory Pathways

Tussilagone has strong anti-inflammatory activity by inhibiting the activation of tumour necrosis factor (TNF)-α, NF-κB, and interleukin-6. This has been demonstrated in vivo to attenuate colonic inflammatory damage in intestinal colitis. A study on tussilagonone, a major sesquiterpene compound in coltsfoot, showed that this constituent induced heme oxygenase-1 (HO-1) expression via the Nrf2 pathway, resulting in suppression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression, both critical mediators of inflammation.

Antitussive and Expectorant Mechanisms

In a study that isolated four caffeoylquinic acids from the ethyl acetate extract of coltsfoot flower buds, the objective was to evaluate antitussive, expectorant, and anti-inflammatory activities. The study concluded that caffeoylquinic acids and their mixture, exhibiting significant antitussive, expectorant, and anti-inflammatory effects, could be considered the main effective ingredients, acting in a collective and synergistic way. In particular, the compound 4,5-di-O-caffeoylquinic acid showed the strongest effect, inhibiting leucocytosis by 49.7%; however, the mechanism of action requires further investigation.

Cardiovascular and Respiratory Stimulation

The cardiorespiratory stimulant capacity of Tussilago farfara has been evaluated; the extract has been found to be a potent respiratory and cardiovascular stimulant, having a dopamine-like pressor effect as tested in rats, dogs, and cats when administered intravenously to anesthetized animals. This blood pressure response was associated with increases in heart rate and respiratory stimulation. It was suggested that the mechanism of action of Tussilago on blood pressure might be due to stimulation of the vasomotor center of the medulla and the vascular α-receptor, and to constriction of the peripheral blood vessels.

Antioxidant Mechanisms

The juice prepared from fresh T. farfara leaves (at dilutions of 1:10 and 1:100) was observed to exhibit significant antimutagenic activity against the genotoxic compound nalidixic acid in an SOS chromotest. Water-soluble polysaccharides present in coltsfoot reduce the toxic effect of paclitaxel on the blood system in mice that have Lewis lung carcinoma.

5. Scientific Evidence by Area of Use

5.1 Respiratory Conditions (Cough, Bronchitis, Asthma)

Overview of evidence: Information supporting antioxidant, antitussive, antimicrobial, or pressor effects of coltsfoot is limited to in vitro and animal studies. Non-clinical research also suggests potential applications in cancer and inflammatory processes. However, clinical data are lacking to recommend coltsfoot for any indication.

Preclinical studies: A study isolated four caffeoylquinic acids from the ethyl acetate extract of coltsfoot flower buds and evaluated their antitussive, expectorant, and anti-inflammatory activities. Mice were orally treated with these compounds and their mixture at doses of 10 and 20 mg/kg once daily for 3 days. The antitussive and expectorant activities were evaluated using the ammonia-liquor-induced model and the phenol red secretion model, and anti-inflammatory activity was evaluated using leukocyte count in bronchoalveolar lavage fluid after ammonia-liquor-induced acute airway inflammation. Modern pharmacological experiments have demonstrated that the water extract of the flower bud exhibited obvious antitussive and expectorant activities in animal models.

Human evidence: No rigorous, controlled clinical trials in humans have been published demonstrating efficacy of coltsfoot for respiratory conditions. Current research continues to investigate its possible anti-inflammatory properties and other health benefits; however, no rigorous clinical trials have confirmed its medicinal effects. The evidence base for the respiratory use of coltsfoot therefore rests on traditional use, in vitro studies, and animal models, with no translating human trial data to support clinical recommendations.

5.2 Anti-inflammatory Activity

Coltsfoot has diverse uses in local and traditional medicine, specifically for relieving inflammatory conditions, respiratory and infectious diseases. Many traditional uses of coltsfoot are supported by modern in vitro or in vivo pharmacological studies such as anti-inflammatory activities, neuroprotective activity, anti-diabetic activity, and antioxidant activity.

Tussilagone (TGN), a sesquiterpenoid isolated from coltsfoot, has been evaluated as a potential treatment against psoriasis, a common inflammatory skin disorder. Biological analysis showed that 41 sesquiterpenoids inhibited nitric oxide (NO) production in LPS-stimulated RAW 264.7 cells, with IC₅₀ values ranging from 3.5 μM to 60.29 μM. These findings are derived from in vitro cell-based models and have not been validated in clinical trials.

5.3 Skin Conditions

Traditional topical applications for coltsfoot have been described across European cultures. The fresh, bruised leaves were applied to boils, abscesses, and suppurating ulcers, and a poultice of the flowers was used for inflamed skin disorders such as eczema, ulcers, sores, varicose veins, and insect bites. There are no controlled human studies validating these topical uses, and this area remains supported only by traditional practice and preclinical data.

5.4 Cardiovascular Effects

The cardiovascular effects of tussilagone have been established only in animal models. Tussilago extract has been found to be a potent respiratory and cardiovascular stimulant, having a dopamine-like pressor effect tested in both rats, dogs, and cats when administered intravenously to anesthetized animals. No human clinical studies of coltsfoot for cardiovascular applications have been conducted.

5.5 Antimicrobial Activity

Coltsfoot essential oil has demonstrated antibacterial activity against Escherichia coli and Staphylococcus aureus in laboratory studies. Antitubercular activity has been reported for Tussilago farfara extracts and constituents in a study published in the Journal of Ethnopharmacology. These findings are limited to in vitro contexts and have not been examined in clinical settings.

5.6 Neuroprotective, Antidiabetic, and Anticancer Activity

The therapeutic potential of coltsfoot is attributed to a diverse phytochemical profile comprising alkaloids, flavonoids, and terpenoids, which contribute to its reported neuroprotective, anti-inflammatory, antioxidant, and anticancer activities. Recent studies have also exhibited the plant's utility in the green synthesis of nanoparticles, especially silver (Ag) and gold (Au), representing notable antibacterial and cytotoxic properties, with promise as anticancer drug delivery agents. All such reports in these areas derive from in vitro and animal experimental models, and no human clinical evidence currently supports these applications.

6. Body Systems Associated with Coltsfoot

• Respiratory system: This medicinal herb is traditionally used as an herbal remedy mainly for the treatment of respiratory tract-related problems. Cough, bronchitis, asthma, laryngitis, and emphysema are the primary conditions documented in both traditional and scientific literature.
• Gastrointestinal system: Due to its mucilage content, coltsfoot has a demulcent action used to soothe irritations in the gastrointestinal tract and treat inflammatory digestive disorders, especially where there is ulceration.
• Integumentary system (skin): Topical use for wounds, burns, ulcers, and eczema is documented in multiple traditional systems, particularly Turkish, Ukrainian, and Polish medicine.
• Cardiovascular system: Animal data indicate a respiratory and cardiovascular stimulant effect mediated by tussilagone, though human evidence is absent.
• Hepatic system: Of particular significance as a site of toxicity from pyrrolizidine alkaloids rather than benefit (see Safety section).

7. Dosage Forms and Reported Dosages

Clinical trials are lacking to provide dosage recommendations for coltsfoot, and information is lacking overall. The only specific dosage information found in authoritative sources pertains to traditional preparations:

• Herbal infusion (tea): Tea of coltsfoot leaf or flower is made by steeping 1–2 teaspoons (5–10 grams) in 1 cup (250 ml) of hot water for ten to twenty minutes, with an amount of three cups (750 ml) daily described in traditional use.
• Preclinical study doses: In mouse studies evaluating caffeoylquinic acids, animals were orally treated at doses of 10 and 20 mg/kg once daily for 3 days. These doses are from animal research and are not directly translatable to human recommendations.
• Honey-processed flower bud (Traditional Chinese Medicine): Dried flower buds (Farfarae Flos) have been employed in TCM for treatment of cough, expectorant, acute and chronic tracheitis, and asthma; honey processing is documented to enhance clinical effect. No specific validated human dosage exists in the reviewed literature.

There is no established safe dosage for coltsfoot. Given the presence of hepatotoxic and carcinogenic pyrrolizidine alkaloids, medical and regulatory bodies advise against the consumption of any part of the plant in any form.

8. Safety: Pyrrolizidine Alkaloids and Hepatotoxicity

Mechanism of Toxicity

The primary health risk associated with coltsfoot stems from its content of unsaturated pyrrolizidine alkaloids (PAs), particularly senkirkine and senecionine. These compounds are metabolized in the liver into highly reactive pyrrolic derivatives, which are cytotoxic and can bind to DNA and other cellular macromolecules, leading to cell death and genetic mutations. This process is the basis for their severe hepatotoxicity and carcinogenicity.

Pyrrolizidine alkaloids are common plant toxins directed against insect herbivores. Unsaturated PAs are known to be hepatotoxic. Many of the PAs are in addition mutagenic, and some may possibly be carcinogenic for humans.

Hepatic Veno-Occlusive Disease

The most critical adverse effect of coltsfoot is hepatotoxicity. The PAs in coltsfoot can cause hepatic veno-occlusive disease (HVOD), also known as sinusoidal obstruction syndrome, which involves blockage of the small veins in the liver, leading to liver congestion, fluid retention (ascites), jaundice, and an enlarged, painful liver. HVOD can rapidly progress to cirrhosis, liver failure, and death.

Documented Clinical Case Reports

A systematic review of case studies published through November 2017 identified three cases of adverse reactions related to coltsfoot, using keyword search terms for PA-related harm and coltsfoot. Of the two assessable cases, one documented a fatal exposure to unsaturated PAs in utero from a multi-herbal tea consumed daily for the duration of pregnancy; the second case was hepatoveno-occlusive disease in an adult female.

Regarding the pediatric veno-occlusive case: veno-occlusive disease was diagnosed in an 18-month-old boy who had regularly consumed a herbal tea mixture since the 3rd month of life. Macroscopic and microscopic analysis of the leaf material indicated that Adenostyles alliariae had been erroneously gathered in place of coltsfoot — the two plants can easily be confused, especially after the flowering period. The child received conservative treatment only and recovered completely within 2 months. This case underscores the importance of accurate botanical identification.

Animal studies using amounts of coltsfoot hundreds of times higher than those used as medicine have shown these alkaloids can cause cancer in animals. A single case of an infant who developed liver disease and died after the mother drank tea containing coltsfoot during pregnancy has been reported, and this eventually led to the banning of coltsfoot in Germany in 1992.

Chronic and Cumulative Exposure Risk

The risk is cumulative, meaning that repeated low-level exposure can still lead to severe liver damage over time. Pyrrolizidine alkaloids are classified as potent carcinogens. Chronic exposure, even at low levels, is associated with an increased risk of developing liver cancer (hepatocellular carcinoma) and potentially other types of tumors.

A risk assessment for herbal medicinal products containing PAs indicates that a life-long exposure to maximally 0.007 μg/kg body weight per day is not expected to be associated with safety concerns.

Variability of PA Content

Coltsfoot leaves are characterized by a high variability of the content of toxic PAs, much higher than in the case of the main active compounds, especially flavonoids and mucilage. This phytochemical variability is mainly genetically determined. Pyrrolizidine alkaloid levels are much higher in the root than in the leaves or flowers.

Regulatory Status

Germany's Commission E previously approved coltsfoot for throat ailments but later retracted this approval due to safety concerns associated with its toxic compounds. Coltsfoot leaf was originally approved for the treatment of sore throats in the German Commission E monograph but has since been banned in Germany for internal use. The European Medicines Agency (EMA) has restricted the internal use of Tussilago preparations containing PAs.

Coltsfoot is considered unsafe; it contains chemicals called hepatotoxic pyrrolizidine alkaloids that can damage the liver or cause cancer. Dietary supplement products sold in the United States are not required to state the amount of PAs they may contain; if the package does not indicate that the product is certified hepatotoxic PA-free, hepatotoxic PAs are likely present.

Pregnancy and Breastfeeding

Coltsfoot is considered unsafe for anyone, but persons who are pregnant should be especially cautious. Coltsfoot preparations containing hepatotoxic PAs might cause birth defects and liver damage. It is not known whether coltsfoot preparations that are free of these chemicals are safe to use during pregnancy, and coltsfoot should therefore be avoided altogether during pregnancy.

Drug and Supplement Interactions

The use of coltsfoot alongside other substances that are metabolized by or are toxic to the liver can potentiate the risk of severe liver damage. These include acetaminophen (paracetamol), certain statins, antifungal agents, and anticonvulsants. Coltsfoot may interact with certain medications, particularly those metabolized by the liver; the pyrrolizidine alkaloids in coltsfoot can increase liver burden when combined with hepatotoxic medications or those requiring hepatic metabolism.

Allergenic Potential and Asteraceae Cross-Reactivity

Animal studies have demonstrated allergenic potential. A warning label regarding the presence of potentially hepatotoxic pyrrolizidine alkaloids has been recommended for all coltsfoot preparations. As a member of the Asteraceae family, coltsfoot may present a risk of cross-reactivity in individuals sensitive to other Asteraceae plants (such as chamomile, ragweed, or chrysanthemums), though this has not been extensively studied for coltsfoot specifically.

PA-Free Cultivars

Horticulturists have developed a form of coltsfoot that does not carry toxic pyrrolizidine alkaloids. When available, products of this type should be safer. Although such a safer form of coltsfoot has been developed, there is still insufficient evidence to support its effectiveness in treating any health conditions.

Botanical Misidentification Risk

Adverse events have resulted from collection of the wrong plant, which contains PAs that became the subject of public concern due to their high toxicity. The value of positive identification is of great importance prior to exploring functional phytochemicals and potential health benefits from botanicals.

9. Summary of Evidence Strength

The overall evidence base for coltsfoot as a therapeutic agent is weak with respect to human clinical data. Coltsfoot has diverse uses in local and traditional medicine, and many traditional uses are supported by modern in vitro or in vivo pharmacological studies for anti-inflammatory activities, neuroprotective activity, anti-diabetic activity, and antioxidant activity. However, well-designed studies in vitro, and particularly in vivo, are required to establish links between the traditional uses and bioactivities, as well as ensure safety before clinical use. Traditional use is relevant because it explains why coltsfoot has been studied for antitussive, expectorant, and anti-inflammatory properties, but it does not establish modern clinical proof. As such, coltsfoot remains a herb with a rich ethnobotanical history, a complex and interesting phytochemistry, a meaningful body of preclinical pharmacological data, and a significant safety liability that has prompted bans on internal use by multiple European regulatory authorities — but without the controlled human clinical trial evidence required to recommend it for any therapeutic indication.

References

• Norani et al. (2020). A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot). Journal of Ethnopharmacology — PMC / PubMed
• A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot) — PubMed Abstract
• Wu QZ et al. (2016). Antitussive, expectorant, and anti-inflammatory activities of four caffeoylquinic acids isolated from Tussilago farfara. Pharmaceutical Biology — Taylor & Francis
• Wu QZ et al. (2016). Antitussive, expectorant, and anti-inflammatory activities of four caffeoylquinic acids isolated from Tussilago farfara — PubMed
• A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot) — ScienceDirect
• Tussilago — ScienceDirect Topics Overview
• Tussilago — Wikipedia
• Adamczak A et al. (2013). Content of pyrrolizidine alkaloids in the leaves of coltsfoot (Tussilago farfara L.) in Poland. Acta Societatis Botanicorum Poloniae
• Risk assessment on the use of herbal medicinal products containing pyrrolizidine alkaloids — ScienceDirect
• Coltsfoot — PeaceHealth Health Information Library (TraceGains)
• Coltsfoot Uses, Benefits & Dosage — Drugs.com Natural Product monograph
• Coltsfoot: Health Benefits, Side Effects, Uses, Dose & Precautions — RxList
• Coltsfoot's Therapeutic Uses — EBSCO Research Starters
• Coltsfoot (Tussilago farfara): Benefits, Safety, Uses — Herbal Reality
• Sperl W et al. (1995). Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. European Journal of Pediatrics — Springer
• Evans S et al. (2019). A Systematic Review of Case Reports of Adverse Events for Borage, Coltsfoot and Comfrey — National Institute of Medical Herbalists (NIMH)
• Coltsfoot (Tussilago farfara L.; Asteraceae): modern methods of extraction, phytochemistry, nanoparticles synthesis, ethnopharmacology, and biological activities — Natural Product Research (Taylor & Francis)
• Coltsfoot — Roots of Medicine, University of Iowa
• The Side Effects of Coltsfoot — Biomedicus